Gladstone Institutional Advisory’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,863
Closed -$573K 812
2025
Q3
$573K Buy
13,863
+105
+0.8% +$4.22K 0.02% 480
2025
Q2
$606K Sell
13,758
-117
-0.8% -$4.68K 0.03% 447
2025
Q1
$512K Buy
+13,875
New +$494K 0.02% 461

Other funds holding EXEL

Gladstone Institutional Advisory's EXEL Position: Q4 2025 in Review

Gladstone Institutional Advisory sold out of Exelixis (EXEL) in Q4 2025, closing a stake of 13,863 shares — an estimated $573K sold.

Gladstone Institutional Advisory first reported a position in EXEL in Q1 2025 and held it in 3 quarters. The position peaked at $606K in Q2 2025. 685 funds tracked by Wall St. Rank hold EXEL as of Q4 2025.

  • Gladstone Institutional Advisory reported no remaining Exelixis position as of Q4 2025 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 13,863 Exelixis shares in Q4 2025, an estimated $573K.
  • Gladstone Institutional Advisory first reported a position in Exelixis in Q1 2025 and held it in 3 quarters.
  • Gladstone Institutional Advisory's Exelixis position peaked at $606K in Q2 2025.
  • 685 funds tracked by Wall St. Rank held Exelixis as of Q4 2025.

Based on Gladstone Institutional Advisory's 13F filing for Q4 2025, filed 17 Feb 2026.